1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Nakamura, G.R. Reynolds, M.E. Chen, Y.M. Starovasnik, M.A. Lowman, H.B. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H2 N 16.023 AMINO GROUP non-polymer C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 99 1303 1308 10.1073/pnas.022635599 11830661 Stable "zeta" peptides that act as potent antagonists of the high-affinity IgE receptor. 2002 10.2210/pdb1kcn/pdb pdb_00001kcn 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2143.615 e109 zeta peptide 1 syn polymer no yes ALCPAVCYVGGKALCPDVCYV(NH2) ALCPAVCYVGGKALCPDVCYVX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_conn struct_site repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-03-06 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id 'Structure of e131 zeta peptide, a potent antagonist of the high-affinity IgE receptor' RCSB Y RCSB 2001-11-09 REL 'solid-phase peptide synthesis of a novel peptide based on a naive phage-peptide library that was sorted for binding to the high-affinity IGE receptor' sample This structure was determined using standard 2D homonuclear techniques. 3JHNHA WERE OBTAINED BY FITTING LORENTZIAN LINES TO THE ANTIPHASE DOUBLETS OF HN-HA PEAKS IN A 2QF-COSY SPECTRUM PROCESSED TO HIGH DIGITAL RESOLUTION IN F2. 3JHAHB WERE EXTRACTED FROM A COSY-35 SPECTRUM ACQUIRED IN D2O structures with acceptable covalent geometry,structures with the least restraint violations 50 20 2D NOESY DQF-COSY 2D TOCSY 2D COSY-35 2D NOESY 2D ROESY 5.4 ambient 288 K The structures are based on a total of 101 NOE-derived distance restraints, 18 dihedral angle restraints, and 12 distant restraints from 6 hydrogen bonds. hybrid distance geometry/simulated annealing, then further refined by restrained molecular dynamics 1 closest to the average 2mM e109 peptide, 92% H2O/8% D2O, pH 5.4, 0.1 mM NaN3, 0.1 mM DSS 92% H2O/8% D2O 2mM e109 peptide, 100% D2O, pH 5.4, 0.1 mM NaN3, 0.1 mM DSS 100% D2O Bruker, Inc. collection XwinNMR 2.1 Molecular Simulations, Inc. data analysis Felix 98.0 Molecular Simulations, Inc. structure solution DGII 98.0 Molecular Simulations, Inc. refinement Discover 98.0 500 Bruker DRX ALA 1 n 1 ALA 1 A LEU 2 n 2 LEU 2 A CYS 3 n 3 CYS 3 A PRO 4 n 4 PRO 4 A ALA 5 n 5 ALA 5 A VAL 6 n 6 VAL 6 A CYS 7 n 7 CYS 7 A TYR 8 n 8 TYR 8 A VAL 9 n 9 VAL 9 A GLY 10 n 10 GLY 10 A GLY 11 n 11 GLY 11 A LYS 12 n 12 LYS 12 A ALA 13 n 13 ALA 13 A LEU 14 n 14 LEU 14 A CYS 15 n 15 CYS 15 A PRO 16 n 16 PRO 16 A ASP 17 n 17 ASP 17 A VAL 18 n 18 VAL 18 A CYS 19 n 19 CYS 19 A TYR 20 n 20 TYR 20 A VAL 21 n 21 VAL 21 A NH2 22 n 22 NH2 22 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A LYS 12 -138.10 -65.55 1 A ALA 13 -160.03 115.58 1 A LEU 14 -153.06 44.15 3 A LEU 2 -153.47 46.17 3 A LYS 12 -162.43 70.77 4 A ALA 13 -144.91 42.62 6 A TYR 8 -137.99 -57.01 6 A ALA 13 -160.64 73.03 6 A LEU 14 -151.92 43.36 8 A CYS 7 -77.17 24.06 8 A TYR 8 -148.77 -55.56 8 A ALA 13 -144.13 53.05 9 A ALA 13 -140.73 37.71 10 A ALA 13 -81.32 39.63 11 A LEU 14 -90.99 59.91 12 A LYS 12 -119.30 -99.26 13 A LEU 14 -108.07 54.09 14 A LYS 12 -161.41 78.22 14 A ALA 13 -80.57 43.57 16 A LEU 14 -101.99 55.04 18 A ALA 13 -74.31 42.54 19 A LEU 14 -163.18 33.05 20 A LEU 14 -153.90 -28.75 Structure of e109 Zeta Peptide, an Antagonist of the High-Affinity IgE Receptor 1 N N A PRO 4 A PRO 4 HELX_P A TYR 8 A TYR 8 5 1 5 A PRO 16 A PRO 16 HELX_P A VAL 21 A VAL 21 1 2 6 disulf 2.047 A CYS 3 A SG CYS 3 1_555 A CYS 19 A SG CYS 19 1_555 disulf 2.042 A CYS 7 A SG CYS 7 1_555 A CYS 15 A SG CYS 15 1_555 covale 1.335 both A VAL 21 A C VAL 21 1_555 A NH2 22 A N NH2 22 1_555 PROTEIN BINDING disulfide-bonded, helical, "zeta" structure, PROTEIN BINDING 1KCN PDB 1 1KCN 1 22 1KCN 1 22 1KCN A 1 1 22 BINDING SITE FOR RESIDUE NH2 A 22 A NH2 22 Software 2 A TYR 20 A TYR 20 2 1_555 A VAL 21 A VAL 21 2 1_555